Avecho Biotechnology Limited (ASX:AVE)

Australia flag Australia · Delayed Price · Currency is AUD
0.0100
0.00 (0.00%)
Jan 30, 2026, 2:42 PM AEST
233.33%
Market Cap36.73M
Revenue (ttm)1.38M +306.9%
Net Income-3.62M
EPS-0.00
Shares Out3.67B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,978,546
Average Volume4,027,324
Open0.0100
Previous Close0.0100
Day's Range0.0100 - 0.0110
52-Week Range0.0030 - 0.0110
Beta1.01
RSI53.57
Earnings DateFeb 26, 2026

About Avecho Biotechnology

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery. Its human health portfolio covers delivery of pharmaceutical products for pain and dermatology applications through gels, injectables, and patches. In additio... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 15
Stock Exchange Australian Securities Exchange
Ticker Symbol AVE
Full Company Profile

Financial Performance

In 2024, Avecho Biotechnology's revenue was 1.13 million, an increase of 139.19% compared to the previous year's 473,551. Losses were -3.12 million, -9.15% less than in 2023.

Financial Statements